CN111480757A - 益生菌海参胶原蛋白复合肽固体饮料 - Google Patents
益生菌海参胶原蛋白复合肽固体饮料 Download PDFInfo
- Publication number
- CN111480757A CN111480757A CN202010386306.0A CN202010386306A CN111480757A CN 111480757 A CN111480757 A CN 111480757A CN 202010386306 A CN202010386306 A CN 202010386306A CN 111480757 A CN111480757 A CN 111480757A
- Authority
- CN
- China
- Prior art keywords
- peptide
- parts
- solid beverage
- sea cucumber
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 78
- 102000008186 Collagen Human genes 0.000 title claims abstract description 52
- 108010035532 Collagen Proteins 0.000 title claims abstract description 52
- 229920001436 collagen Polymers 0.000 title claims abstract description 52
- 235000013361 beverage Nutrition 0.000 title claims abstract description 50
- 239000007787 solid Substances 0.000 title claims abstract description 48
- 239000006041 probiotic Substances 0.000 title claims abstract description 42
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 42
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 30
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 29
- 239000002131 composite material Substances 0.000 title claims abstract description 21
- 102000015636 Oligopeptides Human genes 0.000 claims description 22
- 108010038807 Oligopeptides Proteins 0.000 claims description 22
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 13
- 210000000988 bone and bone Anatomy 0.000 claims description 12
- 241000283690 Bos taurus Species 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 11
- 235000005822 corn Nutrition 0.000 claims description 11
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 9
- 239000011669 selenium Substances 0.000 claims description 9
- 229910052711 selenium Inorganic materials 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000192001 Pediococcus Species 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 12
- 230000002708 enhancing effect Effects 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 11
- 235000015097 nutrients Nutrition 0.000 abstract description 9
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 108700012359 toxins Proteins 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 230000000968 intestinal effect Effects 0.000 abstract description 2
- 206010016946 Food allergy Diseases 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000004932 little finger Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- 241000965254 Apostichopus japonicus Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/41—Pediococcus
- A23V2400/413—Acidilactici
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明提供一种益生菌海参胶原蛋白复合肽固体饮料，通过科学的配伍，胶原蛋白复合肽和非孢子益生菌合理组合，制得益生菌胶原蛋白复合肽固体饮料具有增强免疫力的功效，可促进新陈代谢，促进营养成分的快速吸收，有助于体内血液毒素、垃圾的快速排出，并有助于人体胃肠道的功能改善，排出人体宿便以及肠道毒素；同时，可高温冲饮，耐高温达到85℃，且适用于部分蛋白质易过敏体质的人群，口感好，品质佳，适合推广使用。
Description
技术领域
本发明属于食品技术领域，具体涉及一种益生菌海参胶原蛋白复合肽固体饮料。
背景技术
肽是两个或两个以上的氨基酸以肽键相连的化合物，在人体内起重要生理作用，发挥生理功能，具有活性的多肽称为活性肽，又称生物活性肽或生物活性多肽，目前，它成为全世界研究的热点、大量的国内外研究结果表明：生物活性肽是涉及生物体内多种细胞功能的生物活性物质，在生物体内已发现几百种，不同的生物肽具有不同的结构和生理功能，如抗病毒、抗癌、抗血栓、抗高血压、免疫调节、激素调节、抑菌、降胆固醇等作用。
益生菌是活的微生物，当其以适量施用时可带来健康益处，已经报道了许多益生菌相关的健康益处，综合利用益生菌和活性肽的特性，作为一种健康的功能性食品受到越来越多的关注。
发明专利CN110150472A公开一种活力肽预混料，其将益生菌、活性肽、营养素、生长因子、功能性成分按一定比例混合，将其用做养殖业饲料，具有诱食、增强免疫力、防止肠道、呼吸道疾病的发生、分解霉菌毒素、促进生长等功能。但是，该种多肽预混料仅适用于家禽、家畜、水产养殖行业，有效成分的吸收率并不高。
发明专利CN108142770A公开一种乳肽多元益生菌固体饮料，采用复合菌种、以及添加低聚果糖、多肽粉混合制得的固体饮料，富含膳食纤维、益生元，营养均衡，保质期长，但是该种固体饮料中的益生菌等活性成分易失活，饮料无法在较高温度下冲饮，影响饮用口感。
发明内容
为解决现有技术存在的问题，对现有工艺进行进一步优化，本发明提供一种益生菌海参胶原蛋白复合肽固体饮料及其制备方法，以实现以下发明目的：
1、解决现有的益生菌与肽复合类固体饮料易高温失活，不适用高温冲泡饮用的问题；
2、解决部分人群蛋白质易过敏的问题；
3、可排除体内宿便，改善胃肠道生理功能；
4、提高肽的营养成分吸收量、提高吸收速率；
为解决以上技术问题，本发明采用以下技术方案：
一种益生菌胶原蛋白复合肽固体饮料，包括胶原蛋白复合肽和非孢子益生菌，所述混合物经过干燥制成；所述胶原蛋白复合肽包括植物肽和动物肽；
所述动物肽包括海参胶原蛋白肽、牛骨胶原蛋白肽、酶解卵白蛋白肽中的一种或多种；
所述植物肽为大豆低聚肽、玉米低聚肽中的一种或多种；
所述非孢子益生菌为乳酸片球菌；
所述乳酸片球菌的含量达到3-5×108CFU/g；
所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌4-6份，海参胶原蛋白肽3-5份，牛骨胶原蛋白肽60-65份，大豆低聚肽8-10份，玉米低聚肽6-8份，酶解卵白蛋白肽10-12份，硒0.001-0.01份；
优选地，所述固体饮料的原材料组成为：
5051乳酸片球菌4.8份，海参胶原蛋白肽4份，牛骨胶原蛋白肽64份，大豆低聚肽8.2份，玉米低聚肽7.6份，酶解卵白蛋白肽11.399份，硒0.001份；
其中：
5051乳酸片球菌，有助于消化，助于食物的充分吸收，有助于刺激天然抗体的产生，增强免疫力，帮助肝脏分解乙醇；
海参胶原蛋白肽，海参中含有18种氨基酸，其中有9种人体必需氨基酸，
还具有丰富的牛磺酸、胶原蛋白、粘多糖、硫酸软骨素、海参皂苷、多肽、多种维生素和微量元素，具有防治血管疾病、促进胎儿发育、提高免疫力、增强骨骼、提高记忆力、美容养颜、增强性功能等功效；
牛骨胶原蛋白，可被人体完全吸收，可有效增加皮肤弹性，增加骨骼强度，美白皮肤，降低因钙质缺失导致的骨质疏松问题，可调节身体电解质的平衡；
大豆低聚肽，可以提高免疫力，增强体力，缓解疲劳，降三高等功效；
玉米低聚肽，有保护肝脏，促进酒精代谢，抗氧化、降血压、增强免疫力和增强运动能力的功效；
酶解卵白蛋白肽，可抑制细胞病变，增强人体免疫力，激活细胞活性，清除对人体有害的自由基，修复人体病变细胞，改善新陈代谢能力，促进人体蛋白质、酶和酵素的合成与调控；
硒，具有抗癌变抗氧化的作用，增强人体免疫力，有拮抗重金属的作用，能调节多种维生素的吸收。
本发明通过科学的配伍，将益生菌与动植物多肽、微量元素合理组合，制得益生菌胶原蛋白复合肽固体饮料具有增强免疫力的功效，可促进新陈代谢，促进营养成分的吸收，同时，可高温冲饮，且适用于部分蛋白质易过敏体质的人群，口感好，品质佳，适合推广使用。
采用上述技术方案，本发明的有益效果为：
1、本发明益生菌海参胶原蛋白复合肽固体饮料，益生菌与肽复合类固体饮料的耐高温性能优异，可耐85℃高温，适用于高温冲泡饮用，扩展了温度适应性；
2、本发明益生菌海参胶原蛋白复合肽固体饮料，适用于部分蛋白质易过敏体质的人群；
3、本发明益生菌海参胶原蛋白复合肽固体饮料，可促进新陈代谢，促进营养成分的吸收，肽的营养成分吸收量可接近100%，吸收速率快；
4、本发明益生菌海参胶原蛋白复合肽固体饮料，饮料中活性益生菌含量高，且，固体饮料中的活性益生菌含量达到3-5×108CFU/g；
5、本发明益生菌海参胶原蛋白复合肽固体饮料，可控制三高，抑制癌症、肿瘤细胞的增长，缓解化疗后厌食，修复受损细胞，加快身体康复；具有增强免疫的作用，有助于刺激天然抗体的产生，改善情绪，增加大脑供血，缓解抑郁造成的大脑衰退，加快熬夜者的机体恢复，帮助优化健康体重；
6、本发明益生菌海参胶原蛋白复合肽固体饮料，可帮助消除可能引起炎症和皮肤损伤的毒素，迅速解决皮肤过敏问题，补充人体流失的胶原蛋白，延缓皮肤衰老；
7、本发明益生菌海参胶原蛋白复合肽固体饮料，具有解毒作用，保肝、护肾、解毒、帮助肝脏分解乙醇，提高解酒能力，帮助人体分解食物链中摄入的残留农药、激素、类固醇等有害物质，增强体质，延缓衰老；
8、本发明益生菌海参胶原蛋白复合肽固体饮料，可缓解压力，有助于缓解压力引起的消化系统问题，稳定情绪，改善睡眠，提高视力，提高抗压能力；
9、本发明益生菌海参胶原蛋白复合肽固体饮料，有助于食物的消化，并改善肠胃功能和吸收能力，清除宿便，改善便秘问题，适用于亚健康状态者、体弱多病者以及需要补充营养和能量者；
具体实施方式：
下面结合具体的实施例，进一步阐述本发明。
实施例1一种益生菌海参胶原蛋白复合肽固体饮料
所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌4.8份，海参胶原蛋白肽4份，牛骨胶原蛋白肽64份，大豆低聚肽8.2份，玉米低聚肽7.6份，酶解卵白蛋白肽11.399份，硒0.001份；
实施例2 一种益生菌海参胶原蛋白复合肽固体饮料
所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌4份，海参胶原蛋白肽3份，牛骨胶原蛋白肽65份，大豆低聚肽8份，玉米低聚肽8份，酶解卵白蛋白肽11.399份，硒0.001份；
实施例3一种益生菌海参胶原蛋白复合肽固体饮料
所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌6份，海参胶原蛋白肽5份，牛骨胶原蛋白肽60份，大豆低聚肽10份，玉米低聚肽7.99份，酶解卵白蛋白肽11份，硒0.01份；
实施例4 一种益生菌海参胶原蛋白复合肽固体饮料
所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌6份，海参胶原蛋白肽3份，牛骨胶原蛋白肽62份，大豆低聚肽9份，玉米低聚肽7.992份，酶解卵白蛋白肽12份，硒0.008份；
对实施例1-4制备的固体饮料的营养成分进行测试，结果如下表：
综合营养成分表来看，实施例1为最优技术方案，对实施例1制备的固体饮料的耐高温性能进行测试，将20g固体饮料加入100ml水中溶解，结果如下：
实施例1制备的固体饮料在高温条件下冲泡时益生菌的存活量
作为对比，单独采用5051乳酸片球菌冻干粉末进行耐高温性能进行测试，将20g 5051乳酸片球菌冻干粉末加入100ml水中溶解，结果如下：
由此可见，本发明制备的益生菌海参胶原蛋白复合肽固体饮料，不仅营养物质成分丰富，而且耐高温性能优异，高温失活率低，可适用高温冲泡饮用。
本发明制备的益生菌海参胶原蛋白复合肽固体饮料，使用案例，包括：
刘某某，女，1951年生，山东省潍坊市潍城区人，2000年前突感头昏、头胀症状，就诊经检查患高血压，高压150，低压120，后一直服用西药降压，2020年初开始服用本产品，20天后西药停用，后一直服用至今无明显血压增高现象；
李某某，男，1971年生，山东省东营市海港经济开发区人，1991年因输血原因造成皮肤生癣，多方诊治无效，2019年11月份开始服用本产品，二个月后皮肤癣疥消失，至今无复发；
任某某，男1965年生，山东省潍坊滨海开发区人，2018年因肠道问题便秘，酒后加重，2020年3月份服用本产品，3日之后便秘改善，酒后未见加重现象，至今一直服用；
孙某某，男，1970年生，上海浦东人，2020年4月份，经人介绍服用本产品，2日之后便秘现象消失，至今一直服用本产品；
陈某某，女，1975年生，东营市东营区人2007年身体不适,医院体检查出高血压，高压180，低压110，服用降压药至2019年10月份，经朋友介绍服用本产品，服用2个月之后血压基本正常，停用西药，后至今一直服用本产品，无不良反应；
王某某，男，1976年生，山东潍坊滨海开发区人，教师，左腿膝关节疼痛，右脚小指处疼痛，站立十分钟后症状加重，2020年4月13日经人介绍服用该产品，服用至4月21号，膝关节和小指关节疼痛明显好转，小指关节疼痛症状基本消失。
本发明通过科学的配伍，将益生菌与动植物多肽、微量元素合理组合，制得的益生菌胶原蛋白复合肽固体饮料综合营养成分含量丰富，具有增强免疫力的功效，可促进新陈代谢，促进营养成分的吸收，且适用于部分蛋白质易过敏体质的人群，口感好，品质佳，而且耐高温性能优异，可适用高温冲泡饮用，适合推广使用。
最后应说明的是：以上所述仅为本发明的优选实施例，并不用于限制本发明，尽管参照前述实施例对本发明进行了详细说明，对于本领域的技术人员来说，其依然可以对前述各实施例所记载的技术方案进行修改，或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (5)
1.一种益生菌海参胶原蛋白复合肽固体饮料，其特征在于，所述固体饮料包括胶原蛋白复合肽和非孢子益生菌，经过混合干燥制成，所述非孢子益生菌的含量达3-5×108CFU/g。
2.根据权利要求1所述的固体饮料，其特征在于，所述非孢子益生菌为5051乳酸片球菌。
3.根据权利要求1所述的固体饮料，其特征在于，所述胶原蛋白复合肽包括植物肽和动物肽；
所述动物肽包括海参胶原蛋白肽、牛骨胶原蛋白肽、酶解卵白蛋白肽中的一种或多种；
所述植物肽为大豆低聚肽、玉米低聚肽中的一种或多种。
4.根据权利要求1所述的固体饮料，其特征在于，所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌4-6份，海参胶原蛋白肽3-5份，牛骨胶原蛋白肽60-65份，大豆低聚肽8-10份，玉米低聚肽6-8份，酶解卵白蛋白肽10-12份，硒0.001-0.01份。
5.根据权利要求4所述的固体饮料，其特征在于，所述固体饮料的原材料组成，按重量份数计，包括：
5051乳酸片球菌4.8份，海参胶原蛋白肽4份，牛骨胶原蛋白肽64份，大豆低聚肽8.2份，玉米低聚肽7.6份，酶解卵白蛋白肽11.399份，硒0.001份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010386306.0A CN111480757A (zh) | 2020-05-09 | 2020-05-09 | 益生菌海参胶原蛋白复合肽固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010386306.0A CN111480757A (zh) | 2020-05-09 | 2020-05-09 | 益生菌海参胶原蛋白复合肽固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111480757A true CN111480757A (zh) | 2020-08-04 |
Family
ID=71790937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010386306.0A Pending CN111480757A (zh) | 2020-05-09 | 2020-05-09 | 益生菌海参胶原蛋白复合肽固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111480757A (zh) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496575A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种含短肽和益生菌的特殊营养食品配方 |
| US9289008B1 (en) * | 2011-11-14 | 2016-03-22 | Imaglin Technology, LLC | High temperature, resistant probiotics for food and feed preparations |
| CN107772191A (zh) * | 2017-11-28 | 2018-03-09 | 威海养经堂医药科技有限公司 | 一种海参胶原蛋白肽固体饮料 |
| KR20180001028U (ko) * | 2016-10-05 | 2018-04-13 | 슈-샤 린 | 내고온 프로바이오틱스 커피 생층 구조 |
| CN108294205A (zh) * | 2018-02-02 | 2018-07-20 | 天津科技大学 | 利用青春双歧杆菌和凝结芽孢杆菌发酵制备益生菌饮品或冲调食品的方法 |
| US20180338508A1 (en) * | 2017-05-26 | 2018-11-29 | Muhammed Majeed | Beverage Compositions Containing Bacillus coagulans MTCC 5856 |
| US20190069587A1 (en) * | 2016-04-05 | 2019-03-07 | Nch Corporation | Composition and Method for Germinative Compounds in Probiotic Food and Beverage Products for Human Consumption |
| CN109924505A (zh) * | 2017-12-15 | 2019-06-25 | 上海海洋大学 | 一种新型复合益生菌食品 |
| TW201938033A (zh) * | 2018-03-13 | 2019-10-01 | 麗多國際生技股份有限公司 | 可抑制和改善肥胖的沖泡式可可食品組合物 |
| CN111109492A (zh) * | 2020-01-14 | 2020-05-08 | 上海昊岳食品科技有限公司 | 功能性胶原蛋白肽益生菌固体饮料及其制备方法 |
-
2020
- 2020-05-09 CN CN202010386306.0A patent/CN111480757A/zh active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496575A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种含短肽和益生菌的特殊营养食品配方 |
| US9289008B1 (en) * | 2011-11-14 | 2016-03-22 | Imaglin Technology, LLC | High temperature, resistant probiotics for food and feed preparations |
| US20160193259A1 (en) * | 2011-11-14 | 2016-07-07 | Imagilin Technology, LLC. | High temperature resistant probiotics for food and feed preparations |
| US20190069587A1 (en) * | 2016-04-05 | 2019-03-07 | Nch Corporation | Composition and Method for Germinative Compounds in Probiotic Food and Beverage Products for Human Consumption |
| KR20180001028U (ko) * | 2016-10-05 | 2018-04-13 | 슈-샤 린 | 내고온 프로바이오틱스 커피 생층 구조 |
| US20180338508A1 (en) * | 2017-05-26 | 2018-11-29 | Muhammed Majeed | Beverage Compositions Containing Bacillus coagulans MTCC 5856 |
| CN107772191A (zh) * | 2017-11-28 | 2018-03-09 | 威海养经堂医药科技有限公司 | 一种海参胶原蛋白肽固体饮料 |
| CN109924505A (zh) * | 2017-12-15 | 2019-06-25 | 上海海洋大学 | 一种新型复合益生菌食品 |
| CN108294205A (zh) * | 2018-02-02 | 2018-07-20 | 天津科技大学 | 利用青春双歧杆菌和凝结芽孢杆菌发酵制备益生菌饮品或冲调食品的方法 |
| TW201938033A (zh) * | 2018-03-13 | 2019-10-01 | 麗多國際生技股份有限公司 | 可抑制和改善肥胖的沖泡式可可食品組合物 |
| CN111109492A (zh) * | 2020-01-14 | 2020-05-08 | 上海昊岳食品科技有限公司 | 功能性胶原蛋白肽益生菌固体饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| B5051乳酸片球菌一款超活益生菌: "医迈霖益生菌", 《HTTPS://WWW.MEIPIAN.CN/EHLHAYH》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106261763A (zh) | 一种谷物膳食纤维代餐粉及其制备方法 | |
| KR101539382B1 (ko) | 장 기능 개선 및 배변 촉진용 식품 조성물 | |
| CN106806643A (zh) | 一种治疗糖尿病的中药组合物 | |
| CN104855994A (zh) | 肾病非全营养配方食品 | |
| CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
| CN101433267B (zh) | 鸡用饲料添加剂 | |
| CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
| CN105533688A (zh) | 一种辅助降血糖保健软胶囊及其制备方法 | |
| CN108968037A (zh) | 老年痴呆症全营养配方食品 | |
| CN103734581B (zh) | 适用于术后人群康复的牦牛乳蛋白多肽营养粉及其制备方法 | |
| CN107334156A (zh) | 催乳全营养配方食品 | |
| CN107319550A (zh) | 脑外伤全营养配方食品 | |
| CN104187637A (zh) | 壮阳全营养配方食品 | |
| CN105878397A (zh) | 一种调节牛羊运输应激组合物 | |
| CN103704568B (zh) | 临床膳食食品 | |
| WO2022165700A1 (zh) | 一种多肽营养粉及其制备方法 | |
| CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
| CN104839704A (zh) | 壮阳非全营养配方食品 | |
| CN104839671A (zh) | 壮阳医学配方食品 | |
| CN108371709A (zh) | 黑枸杞肿瘤康复基因酶 | |
| CN111480757A (zh) | 益生菌海参胶原蛋白复合肽固体饮料 | |
| CN113812637A (zh) | 术前术后营养补充剂及应用 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| CN102366041B (zh) | 适用于患者术后调养的营养粉 | |
| CN106036880A (zh) | 一种缓解痛经的组合物及其应用和由其制成的健康食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210913 Address after: 261011 1302, unit 2, building 8, Chongjin chadu, Weicheng District, Weifang City, Shandong Province Applicant after: Gao Shufang Address before: 262100 room 402, South Shengcheng building, 300m west of the intersection of Shengcheng street and Chenming Road, Shengcheng street, Shouguang City, Weifang City, Shandong Province Applicant before: Hongcheng Lihua Biotechnology (Shandong) Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200804 |
|
| RJ01 | Rejection of invention patent application after publication |